These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 18832751)

  • 1. Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque.
    Shaw JA; Bobik A; Murphy A; Kanellakis P; Blombery P; Mukhamedova N; Woollard K; Lyon S; Sviridov D; Dart AM
    Circ Res; 2008 Nov; 103(10):1084-91. PubMed ID: 18832751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.
    Patel S; Drew BG; Nakhla S; Duffy SJ; Murphy AJ; Barter PJ; Rye KA; Chin-Dusting J; Hoang A; Sviridov D; Celermajer DS; Kingwell BA
    J Am Coll Cardiol; 2009 Mar; 53(11):962-71. PubMed ID: 19281927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging high-density lipoprotein infusion therapies: fulfilling the promise of epidemiology?
    Tardif JC
    J Clin Lipidol; 2010; 4(5):399-404. PubMed ID: 21122683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconstituted HDL in acute coronary syndromes.
    Chenevard R; Hürlimann D; Spieker L; Béchir M; Enseleit F; Hermann M; Flammer AJ; Sudano I; Corti R; Lüscher TF; Noll G; Ruschitzka F
    Cardiovasc Ther; 2012 Apr; 30(2):e51-7. PubMed ID: 20840194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endotoxin-induced mortality in bile duct-ligated rats after administration of reconstituted high-density lipoprotein.
    Sewnath ME; Levels HH; Oude Elferink R; van Noorden CJ; ten Kate FJ; van Deventer SJ; Gouma DJ
    Hepatology; 2000 Dec; 32(6):1289-99. PubMed ID: 11093736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial.
    Tardif JC; Grégoire J; L'Allier PL; Ibrahim R; Lespérance J; Heinonen TM; Kouz S; Berry C; Basser R; Lavoie MA; Guertin MC; Rodés-Cabau J;
    JAMA; 2007 Apr; 297(15):1675-82. PubMed ID: 17387133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological intervention using reconstituted high-density lipoprotein changes in the lipid profile in spontaneously hypersensitive rats.
    Imaizumi S; Kiya Y; Miura S; Zhang B; Matsuo Y; Uehara Y; Rye KA; Saku K
    Clin Exp Hypertens; 2010 May; 32(3):202-8. PubMed ID: 20504129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits.
    Nicholls SJ; Dusting GJ; Cutri B; Bao S; Drummond GR; Rye KA; Barter PJ
    Circulation; 2005 Mar; 111(12):1543-50. PubMed ID: 15781735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A first-in-man, randomized, placebo-controlled study to evaluate the safety and feasibility of autologous delipidated high-density lipoprotein plasma infusions in patients with acute coronary syndrome.
    Waksman R; Torguson R; Kent KM; Pichard AD; Suddath WO; Satler LF; Martin BD; Perlman TJ; Maltais JA; Weissman NJ; Fitzgerald PJ; Brewer HB
    J Am Coll Cardiol; 2010 Jun; 55(24):2727-35. PubMed ID: 20538165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmogenic effect of reconstituted high-density lipoprotein against ischemia/reperfusion in rats.
    Imaizumi S; Miura S; Nakamura K; Kiya Y; Uehara Y; Zhang B; Matsuo Y; Urata H; Ideishi M; Rye KA; Sata M; Saku K
    J Am Coll Cardiol; 2008 Apr; 51(16):1604-12. PubMed ID: 18420105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infusion of Reconstituted High-Density Lipoprotein, CSL112, in Patients With Atherosclerosis: Safety and Pharmacokinetic Results From a Phase 2a Randomized Clinical Trial.
    Tricoci P; D'Andrea DM; Gurbel PA; Yao Z; Cuchel M; Winston B; Schott R; Weiss R; Blazing MA; Cannon L; Bailey A; Angiolillo DJ; Gille A; Shear CL; Wright SD; Alexander JH
    J Am Heart Assoc; 2015 Aug; 4(8):e002171. PubMed ID: 26307570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines.
    Sachdeva A; Cannon CP; Deedwania PC; Labresh KA; Smith SC; Dai D; Hernandez A; Fonarow GC
    Am Heart J; 2009 Jan; 157(1):111-117.e2. PubMed ID: 19081406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ApoA-1 infusion reduces arterial cholesterol and myocardial lesions in a rat model of cardiac dysfunction and insulin resistance.
    Borthwick F; Warnakula S; Mangat R; Uwiera RR; Russell JC; Kelly SE; Lee CY; Hryshko L; Mamo JC; Rye KA; Lopaschuk GD; Proctor SD
    Atherosclerosis; 2012 Jun; 222(2):402-8. PubMed ID: 22483015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the Effect of a Single Infusion of Reconstituted High-Density Lipoprotein in Patients with Symptomatic Carotid Plaques.
    Nasr H; Torsney E; Poston RN; Hayes L; Gaze DC; Basser R; Thompson MM; Loftus IM; Cockerill GW
    Ann Vasc Surg; 2015 Oct; 29(7):1380-91. PubMed ID: 26140943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of cholesterol efflux in humans after infusion of reconstituted high-density lipoprotein.
    Hoang A; Drew BG; Low H; Remaley AT; Nestel P; Kingwell BA; Sviridov D
    Eur Heart J; 2012 Mar; 33(5):657-65. PubMed ID: 21498847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: two clinical trials in healthy volunteers and patients with hereditary angioedema.
    Birjmohun RS; Kees Hovingh G; Stroes ES; Hofstra JJ; Dallinga-Thie GM; Meijers JC; Kastelein JJ; Levi M
    Clin Ther; 2008 Dec; 30(12):2314-23. PubMed ID: 19167590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconstituted high-density lipoprotein attenuates platelet function in individuals with type 2 diabetes mellitus by promoting cholesterol efflux.
    Calkin AC; Drew BG; Ono A; Duffy SJ; Gordon MV; Schoenwaelder SM; Sviridov D; Cooper ME; Kingwell BA; Jackson SP
    Circulation; 2009 Nov; 120(21):2095-104. PubMed ID: 19901191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study).
    Cui Y; Watson DJ; Girman CJ; Shapiro DR; Gotto AM; Hiserote P; Clearfield MB
    Am J Cardiol; 2009 Sep; 104(6):829-34. PubMed ID: 19733719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of treatment of severe high-density lipoprotein cholesterol deficiency in men with daily atorvastatin (20 mg) versus fenofibrate (200 mg) versus extended-release niacin (2 g).
    Alrasadi K; Awan Z; Alwaili K; Ruel I; Hafiane A; Krimbou L; Genest J
    Am J Cardiol; 2008 Nov; 102(10):1341-7. PubMed ID: 18993152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of serum high-density lipoprotein cholesterol level as an independent predictor of one-year mortality after percutaneous coronary interventions.
    Ghazzal ZB; Dhawan SS; Sheikh A; Douglas JS; Veledar E; Mavromatis K; Pohlel FK; Vaccarino V
    Am J Cardiol; 2009 Apr; 103(7):902-6. PubMed ID: 19327413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.